Company News For Oct 2, 2019

NERV REED

  • Shares of Roan Resources, Inc. gained 21.1% after the energy company agreed to be acquired by Citizen Energy in an all-cash transaction valued at $1 billion.
  • Shares of Conformis, Inc. rose 19.4% after the medical technology company announced it had entered development, license and distribution agreements with Stryker.
  • Shares of Minerva Neurosciences, Inc. (NERV - Free Report) declined 26.3% after the clinical-stage biopharmaceutical company delayed the results of its drug for Schizophrenia.
  • Shares of Reed's, Inc. (REED - Free Report) dropped 25.7% after the company issued weak guidance for preliminary third-quarter sales.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>